-
Burberry returns to full-year profit on turnaround plan
-
Spiky, polarising, rarely dull: ups and downs of rugby's Eddie Jones
-
Denmark, Australia in the spotlight in Eurovision second semi
-
Heavy Russian strikes on Kyiv kill one, wound 31
-
Xi warns Trump on Taiwan at Beijing summit
-
Iran war and oil dominate BRICS meet in India
-
Bone appetit: Paris pups lap up treats at dog-centric spots
-
Kohli senses end after roaring back to form with IPL century
-
India bars sugar exports until September
-
Madonna, Shakira, BTS to headline first World Cup final half-time show
-
Japan takes 'half step' toward fixing slow retrial system
-
Honda posts operating loss, first since 1957
-
Madonna, Shakira, BTS to headline World Cup final half-time show
-
A quarter of World Cup games risk searing heat: scientists
-
Six hantavirus cruise passengers head to Australia
-
Suspect detained in Philippine senate gunfire: police
-
Cavs top Pistons in overtime for 3-2 series lead
-
Canadian football ready for World Cup coming out party
-
US court suspends sanctions on UN expert on Palestinians
-
Asia markets mixed as Trump-Xi summit, AI trade dominate
-
'Promised to us': The Israelis dreaming of settling south Lebanon
-
'Rare, meaningful': North Korean football team ventures into South
-
In-form Messi hits brace as Miami win 5-3 at Cincinnati in MLS
-
Historic Swiss solar-powered plane crashes into sea
-
A woman UN leader is 'historical justice,' says Ecuadoran contender for top job
-
Indian pharma fuels Africa's 'zombie drug' and opioid crisis
-
After months of blackout, Iran gives internet to select few
-
Wood urges New Zealand to 'create some history' at World Cup
-
In Washington, the fight to preserve Black cemeteries
-
US children's book author sentenced to life after poisoning husband
-
Emotional Vin Diesel leads 'Fast and Furious' tribute in Cannes
-
PLAS-LABS Simplifies Scientific Validation With Automated Citation Tracking Powered by Bioz
-
Battery X Metals Achieves Milestone with Delivery of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Machine Featuring Design Enhancements, Advancing Strategic Commercialization Initiatives
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 14
-
Akkodis Recognized in HFS Horizons 2026 Report for Enterprise Ready Agentic AI Services
-
Lexus Of Oakville Recognized for Redefining the Luxury Dealership Experience With 2026 Consumer Choice Award
-
US renews offer of $100 mn to Cuba if it cooperates
-
City still 'alive' but need Arsenal slip: Guardiola
-
Man City ease past Palace to keep pressure on Arsenal
-
Alaves end champions Barca's bid for 100-point record
-
US jury begins deliberations on 737 MAX victim suit against Boeing
-
PSG clinch fifth straight Ligue 1 title
-
Inter Milan win Italian Cup to secure domestic double
-
Man City see off Palace to keep pressure on Arsenal
-
Trump and Xi set for high-stakes talks in Beijing
-
S&P 500, Nasdaq end at records as oil prices retreat
-
Iran holds World Cup send-off for national football team
-
McIlroy's toe 'totally fine' after nine-hole PGA practice
-
Rare 'Ocean Dream' blue-green diamond sells for $17 mn at auction
-
California says probing possible violations over World Cup ticket sales
Trump ties autism risk to Tylenol as scientists urge caution
US President Donald Trump on Monday urged pregnant people not to take Tylenol over an unproven link to autism, and urged major changes to the standard vaccines given to babies.
The announcement comes as the White House has vowed to revolutionize health in the United States, as experts across medicine and science voice broad concern over the administration's initiatives.
Medical professionals have long cited acetaminophen as among the safest painkillers to take during pregnancy, especially as fever and pain can also pose dangers to both the mother and the developing fetus.
But Trump insisted that "taking Tylenol is not good."
"For this reason, they are strongly recommending that women limit Tylenol use during pregnancy unless medically necessary. That's for instance, in cases of extremely high fever that you feel you can't tough it out," he said.
During his news conference Trump then pushed major changes to the routine vaccine schedule given to infants, insisting without evidence that there's "no reason" to vaccinate newborns against the incurable, highly contagious Hepatitis B.
Repeating anti-vaccine movement talking points, Trump said "I would say, wait until the baby is 12 years old and formed."
That statement stands in direct contradiction in the face of broad medical consensus formed over decades that the best way to prevent maternal transmission of the disease that can cause liver damage and cancer is to vaccinate newborns within the first day of life.
His statement comes days after an influential advisory panel handpicked by health chief Robert F. Kennedy Jr. stopped short of advising that a delay of one month of the first dose of Hepatitis B was warranted.
They deemed more discussion was necessary -- offering temporary relief to many experts in public health who said delaying that shot could have dire results.
- New therapy approved -
Identifying the cause of autism -- a complex condition connected to brain development that many experts believe occurs for predominantly genetic reasons -- has been a pet cause of Trump's controversial health chief Robert F. Kennedy Jr.
Earlier this year, Kennedy -- well-known for his anti-vaccine views and penchant for conspiracy theories -- vowed he would release findings regarding autism's cause by September 2025.
The administration's recent initiative to uncover autism's roots has been widely criticized. Kennedy has spent decades pushing discredited claims that link vaccines to autism.
He touted the drug leucovorin, a form of vitamin B first used to alleviate chemotherapy side effects, as an "exciting therapy" that could help children with autism.
The FDA on Monday said it was approving the drug's tablet form to help a subset of children who have "cerebral folate deficiency."
The Trump government's expected focus on acetaminophen, the active ingredient in Tylenol, is likely to meet broad critique.
The American College of Obstetricians and Gynecologists are among the major medical groups who have identified Tylenol as among the safest options for pain relief and fever reduction during pregnancy. Doctors already warn against its long-term use.
Another common over-the-counter pain reliever, ibuprofen, is generally considered unsafe for pregnant people, especially after the 20th week.
- 'Nuanced and uncertain' -
A literature review published last month concluded there was reason to believe a possible link between Tylenol exposure and autism existed -- but other studies have found an opposite result.
Researchers behind the August report cautioned that more study is needed and that pregnant people should not stop taking medication without consulting their doctors.
David Mandell, a psychiatric epidemiologist at the University of Pennsylvania, told AFP that research suggests the possible risks posed by taking Tylenol while pregnant seem "to be lower than the risk of having an uncontrolled infection during pregnancy."
The professor of psychiatry also emphasized that digging into the interaction of genetic and environmental factors is an area of critical research, but that to take on those studies with rigor demands decades of study and funding -- and cast the Trump administration's efforts as rushed.
The Coalition of Autism Scientists earlier called it "highly irresponsible and potentially dangerous to claim links between potential exposures and autism when the science is far more nuanced and uncertain."
"Secretary Kennedy's announcement will cause confusion and fear," said the group in a statement.
L.Adams--AT